Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentSelling, General & Administrative
Others
Ratios

Adial Pharmaceuticals (ADIL) Shares Outstanding (2022 - 2024)

Adial Pharmaceuticals' Shares Outstanding history spans 3 years, with the latest figure at $6.4 million for Q3 2024.

  • For Q3 2024, Shares Outstanding rose 425.93% year-over-year to $6.4 million; the TTM value through Sep 2024 reached $6.4 million, up 425.93%, while the annual FY2023 figure was $66381.0, 93.78% down from the prior year.
  • Shares Outstanding for Q3 2024 was $6.4 million at Adial Pharmaceuticals, up from $4.3 million in the prior quarter.
  • Across five years, Shares Outstanding topped out at $26.9 million in Q3 2022 and bottomed at $66381.0 in Q4 2023.
  • The 3-year median for Shares Outstanding is $4.1 million (2024), against an average of $8.7 million.
  • The largest annual shift saw Shares Outstanding crashed 95.46% in 2023 before it skyrocketed 425.93% in 2024.
  • A 3-year view of Shares Outstanding shows it stood at $1.1 million in 2022, then tumbled by 93.78% to $66381.0 in 2023, then soared by 9550.02% to $6.4 million in 2024.
  • Per Business Quant, the three most recent readings for ADIL's Shares Outstanding are $6.4 million (Q3 2024), $4.3 million (Q2 2024), and $4.1 million (Q1 2024).